Chiesi Group's new Biotech Center of Excellence brings the future of medicine to Parma

Contributed by: PR Newswire

Tags

CHIESI-Biotech-Centre

More Like This

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges

Guido, Paolo and Luca Barilla. © Barilla

Barilla Opens Its New Innovation Center to Drive Food Innovation Worldwide

Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025

PR Newswire associated0

Solvias Opens Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park

PR Newswire associated0

Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California

PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. (Photo: Business Wire)

PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products

PR Newswire associated0

Fifteen Years Alongside Europe's Drug Discovery Teams: Viva Biotech Strengthens Continuity from Discovery to Development and Manufacturing